Company Filing History:
Years Active: 1998
Title: Hilmar Stolte: Innovator in Tumor Therapy
Introduction
Hilmar Stolte is a notable inventor based in Bad Oeynhausen, Germany. He has made significant contributions to the field of tumor therapy through his innovative research and patents. His work focuses on the use of flavolignans as adjuvants in chemotherapeutic treatments.
Latest Patents
Hilmar Stolte holds a patent titled "Use of flavolignans as adjuvants in tumour therapy." This invention addresses the application of flavolignans to enhance the effectiveness of chemotherapy and protect cells in the urogenital region during treatment.
Career Highlights
Stolte is associated with Madaus AG, where he has been instrumental in advancing research related to tumor therapies. His dedication to improving patient outcomes through innovative solutions is evident in his work.
Collaborations
He has collaborated with notable colleagues, including Hans Lentzen and Ulrich Mengs, to further his research and development efforts in the field.
Conclusion
Hilmar Stolte's contributions to tumor therapy through his patent on flavolignans highlight his commitment to medical innovation. His work continues to influence the landscape of cancer treatment and patient care.